FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2059649085> ?p ?o ?g. }

• W2059649085 endingPage "1109" @default.
• W2059649085 startingPage "1100" @default.
• W2059649085 abstract "OBJECTIVE To assess and compare the therapeutic efficacy and safety of metformin (M) and sulfonylurea (glyburide, G), alone and in various combinations, in patients with non-insulin-dependent diabetes mellitus (NIDDM). RESEARCH DESIGN AND METHODS Of 165 patients (fasting blood glucose [FBG] ≥ 6.7 mmol/l) initially treated with diet alone, 144 (FBG still ≥6.7 mmol/l) were randomized to double-blind, double-dummy controlled treatment with M, G, or primary combination therapy (MG). The dose was titrated, withFBG &lt;6.7 mmol/l as target, using, at most, six dose levels. The first three dose levels comprised increasing single-drug therapy (M or G) or primary combination at increasing but low dosage (MGL), and the second three levels were composed of various high-dose combinations, i.e., add-on therapy (M/G or G/M) and primary combination escalated to high dosage (MGH). Medication was maintained for 6 months after completed dose titration. RESULTS The FBG target was achieved in 9% of patients after diet alone. Single-drug therapy was insufficient in 36% and MGL in 25% (NS) of the randomized patients. There was further improvement in glucose control by the high-dose combinations. Mean FBG ± SE was reduced (P = 0.001) from 9.1 ± 0.4 to 7.0 ± 0.2 mmol/l in those maintained on single-drug treatment or low-dose primary combination. Those treated with different high-dose combinations had a large mean FBG reduction, from 13.3 ± 0.8 to 7.8 ± 0.6 mmol/l. HbA1c levels showed corresponding reductions, and glycemic levels rose after drug discontinuation. Fasting C-peptide rose during treatment with G and MGL but not with M, while fasting insulin was not significantly changed. Meal-stimulated C-peptide and insulin levels were unchanged by M but increased by G and, to a lesser extent, by MGL. There were no significant insulin or C-peptide differences between the different high-dose combinations (M/G, G/M, and MGH). Body weight did not change following treatment with M or combination but increased by 2.8 ± 0.7 kg following G alone. Blood pressure was unchanged. Overall effects on plasma lipids were small, with no significant differences between groups. Drug safety was satisfactory, even if the reporting of (usually modest) adverse events was high; the profile, but not the frequency, differed between groups. CONCLUSIONS Dose-effect titrated treatment with either metformin or glyburide promotes equal degrees of glycemic control. The former, but not the latter, is able to achieve this control without increasing body weight or hyperinsulinemia. Near-normal glycemia can be obtained by a combination of metformin and sulfonylurea, even in advanced NIDDM." @default.
• W2059649085 created "2016-06-24" @default.
• W2059649085 creator A5010357575 @default.
• W2059649085 creator A5034516594 @default.
• W2059649085 creator A5059661783 @default.
• W2059649085 creator A5059674669 @default.
• W2059649085 creator A5080491827 @default.
• W2059649085 creator A5086496273 @default.
• W2059649085 date "1994-10-01" @default.
• W2059649085 modified "2023-10-16" @default.
• W2059649085 title "Therapeutic Comparison of Metformin and Sulfonylurea, Alone and in Various Combinations: A double-blind controlled study" @default.
• W2059649085 doi "https://doi.org/10.2337/diacare.17.10.1100" @default.
• W2059649085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7821128" @default.
• W2059649085 hasPublicationYear "1994" @default.
• W2059649085 type Work @default.
• W2059649085 sameAs 2059649085 @default.
• W2059649085 citedByCount "327" @default.
• W2059649085 countsByYear W20596490852012 @default.
• W2059649085 countsByYear W20596490852013 @default.
• W2059649085 countsByYear W20596490852014 @default.
• W2059649085 countsByYear W20596490852015 @default.
• W2059649085 countsByYear W20596490852016 @default.
• W2059649085 countsByYear W20596490852017 @default.
• W2059649085 countsByYear W20596490852018 @default.
• W2059649085 countsByYear W20596490852019 @default.
• W2059649085 countsByYear W20596490852020 @default.
• W2059649085 countsByYear W20596490852021 @default.
• W2059649085 countsByYear W20596490852022 @default.
• W2059649085 countsByYear W20596490852023 @default.
• W2059649085 crossrefType "journal-article" @default.
• W2059649085 hasAuthorship W2059649085A5010357575 @default.
• W2059649085 hasAuthorship W2059649085A5034516594 @default.
• W2059649085 hasAuthorship W2059649085A5059661783 @default.
• W2059649085 hasAuthorship W2059649085A5059674669 @default.
• W2059649085 hasAuthorship W2059649085A5080491827 @default.
• W2059649085 hasAuthorship W2059649085A5086496273 @default.
• W2059649085 hasConcept C126322002 @default.
• W2059649085 hasConcept C126894567 @default.
• W2059649085 hasConcept C134018914 @default.
• W2059649085 hasConcept C168563851 @default.
• W2059649085 hasConcept C2776999253 @default.
• W2059649085 hasConcept C2778854520 @default.
• W2059649085 hasConcept C2779306644 @default.
• W2059649085 hasConcept C2780035454 @default.
• W2059649085 hasConcept C2780323712 @default.
• W2059649085 hasConcept C555293320 @default.
• W2059649085 hasConcept C71924100 @default.
• W2059649085 hasConcept C90924648 @default.
• W2059649085 hasConcept C98274493 @default.
• W2059649085 hasConceptScore W2059649085C126322002 @default.
• W2059649085 hasConceptScore W2059649085C126894567 @default.
• W2059649085 hasConceptScore W2059649085C134018914 @default.
• W2059649085 hasConceptScore W2059649085C168563851 @default.
• W2059649085 hasConceptScore W2059649085C2776999253 @default.
• W2059649085 hasConceptScore W2059649085C2778854520 @default.
• W2059649085 hasConceptScore W2059649085C2779306644 @default.
• W2059649085 hasConceptScore W2059649085C2780035454 @default.
• W2059649085 hasConceptScore W2059649085C2780323712 @default.
• W2059649085 hasConceptScore W2059649085C555293320 @default.
• W2059649085 hasConceptScore W2059649085C71924100 @default.
• W2059649085 hasConceptScore W2059649085C90924648 @default.
• W2059649085 hasConceptScore W2059649085C98274493 @default.
• W2059649085 hasIssue "10" @default.
• W2059649085 hasLocation W20596490851 @default.
• W2059649085 hasLocation W20596490852 @default.
• W2059649085 hasOpenAccess W2059649085 @default.
• W2059649085 hasPrimaryLocation W20596490851 @default.
• W2059649085 hasRelatedWork W2105403615 @default.
• W2059649085 hasRelatedWork W2353073041 @default.
• W2059649085 hasRelatedWork W2388866597 @default.
• W2059649085 hasRelatedWork W2431567440 @default.
• W2059649085 hasRelatedWork W2520648843 @default.
• W2059649085 hasRelatedWork W2792502347 @default.
• W2059649085 hasRelatedWork W2965764969 @default.
• W2059649085 hasRelatedWork W4293579534 @default.
• W2059649085 hasRelatedWork W1831980957 @default.
• W2059649085 hasRelatedWork W1920632900 @default.
• W2059649085 hasVolume "17" @default.
• W2059649085 isParatext "false" @default.
• W2059649085 isRetracted "false" @default.
• W2059649085 magId "2059649085" @default.
• W2059649085 workType "article" @default.